Mutual Of America Capital Management LLC Karuna Therapeutics, Inc. Transaction History

Mutual Of America Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 26, 2024	SELL	$161.01 - $317.85 $53,938 - $106,479	-335 Reduced 4.38%	7,311 $2.31 Million
Q3 2023 Nov 09, 2023	SELL	$164.66 - $218.08 $1.41 Million - $1.86 Million	-8,535 Reduced 52.75%	7,646 $1.29 Million
Q2 2023 Aug 11, 2023	SELL	$176.32 - $240.22 $215,110 - $293,068	-1,220 Reduced 7.01%	16,181 $3.51 Million
Q1 2023 May 04, 2023	BUY	$161.33 - $204.36 $139,711 - $176,975	866 Added 5.24%	17,401 $3.16 Million
Q4 2022 Feb 10, 2023	BUY	$191.53 - $236.82 $891,955 - $1.1 Million	4,657 Added 39.21%	16,535 $3.25 Million
Q3 2022 Nov 08, 2022	BUY	$123.79 - $277.42 $1.47 Million - $3.3 Million	11,878 New	11,878 $2.67 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mutual Of America Capital Management LLC with notifications on news.